Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep-Oct;31(5):1-6.

Competing commitments in clinical trials

Affiliations

Competing commitments in clinical trials

Charles W Lidz et al. IRB. 2009 Sep-Oct.

Abstract

Most discussion about clinical care in clinical trials has concerned whether subjects’ care may be compromised by research procedures. The possibility that clinical researchers might give priority to helping their “patients” even if that required deviating from the imperatives of the research protocol largely has been ignored. We conducted an on-line survey with clinical researchers, including physicians, research nurses and other research staff, to assess the ways and frequency with which clinical trials may be at risk for being compromised by clinical researchers’ attempting to address the clinical needs of subjects. The survey covered recruitment, clinical management while in the trial, and termination decisions. It produced a 72.0% response rate. Over 20% of respondents agreed that researchers should deviate from the protocol to improve subjects’ care; 28% reported that medications restricted by the protocol were given; 21% reported that subjects who were not eligible had been recruited; and 9% said subjects had been retained in a trial despite meeting termination criteria. Some respondents reported that these deviations from the protocol happened many times. The ramifications of these findings are discussed.

PubMed Disclaimer

Conflict of interest statement

No authors had conflicts of interest with this study.

Similar articles

Cited by

References

    1. Miller FG, Rosenstein DL. The Therapeutic Orientation to Clinical Trials. New England Journal of Medicine. 2003 Apr 3;384(14):1383–86. - PubMed
    1. Marquis D. Leaving therapy to chance: The Hastings Center Report. 1983. - PubMed
    1. Helman S, Helman D. Of mice and men: problems of the randomized clinical trial. New England Journal of Medicine. 1991;324:1585–9. - PubMed
    1. Gifford F. Community-equipoise and the ethics of randomized clinical trials. Bioethics. 1995;9(2):127–48. - PubMed
    1. Poisson R. Fraud in breast-cancer trials. The New England Journal of Medicine. 1994;330(20):1460. - PubMed

Publication types

LinkOut - more resources